Global Medical Oxygen
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Medical Oxygen market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Medical Oxygen market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Form Segment Analysis | Liquid Oxygen , Compressed , Oxygen Concentrators , Others |
| Application Segment Analysis | COPD , Bronchopulmonary , Lung Disorder , Heart Failure , Asthma , Cystic Fibrosis , Others |
| End-User Segment Analysis | Hospitals , Ambulatory Centres , Emergency Medical Centres , Homecare |
|---|---|
| Purity Segment Analysis | 96% to 99.5% , 93% to 96% |
| Delivery Segment Analysis | Aerial Diffusion , Direct Inhalation , Others |
| Modality Segment Analysis | Portable Medical Oxygen Systems , Standalone Medical Oxygen Systems , Market Split by Technology , Continuous Flow , Pulse Dose |
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Medical Oxygen Market Report 2025.
The global medical oxygen market is poised for robust growth, projected to expand from $2,488.69 million in 2021 to $5,751.3 million by 2033, registering a compound annual growth rate (CAGR) of 7.23%. This expansion is primarily fueled by the increasing prevalence of chronic respiratory diseases such as COPD and asthma, a growing geriatric population worldwide, and rising healthcare expenditures. The COVID-19 pandemic highlighted critical gaps in oxygen supply, accelerating investments in healthcare infrastructure and on-site oxygen generation. While North America and Europe currently represent major market shares, the Asia-Pacific region is emerging as the fastest-growing market, driven by developing healthcare systems in countries like China and India. The market is also witnessing a significant technological shift towards more portable and user-friendly devices like portable oxygen concentrators (POCs), catering to the rising demand for home healthcare.
The global medical oxygen market demonstrates a strong upward trajectory, underpinned by its essential role in healthcare. The market is driven by fundamental health trends and is evolving with technological advancements in oxygen production and delivery. Dynamics vary significantly by region, with mature markets focusing on technology upgrades and homecare solutions, while developing markets prioritize establishing reliable and accessible oxygen supply chains to meet burgeoning healthcare demands.
Increasing Prevalence of Respiratory Diseases: A rising global incidence of chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other respiratory conditions is a primary driver for consistent demand for medical oxygen for both hospital and homecare use.
Growing Geriatric Population: The world's aging population is more susceptible to chronic illnesses and respiratory ailments, leading to increased hospitalization rates and a greater need for long-term oxygen therapy, thereby fueling market growth.
Post-Pandemic Healthcare Infrastructure Investment: The COVID-19 pandemic exposed vulnerabilities in oxygen supply chains, spurring governments and healthcare organizations globally to invest heavily in strengthening their respiratory care infrastructure, including on-site oxygen plants and robust supply networks.
Shift Towards Portable Oxygen Concentrators (POCs): There is a growing preference for POCs over traditional oxygen tanks, especially in the homecare segment. This trend is driven by patients' desires for greater mobility, independence, and quality of life.
Adoption of On-site Oxygen Generation: Hospitals and larger healthcare facilities are increasingly installing Pressure Swing Adsorption (PSA) and Vacuum Pressure Swing Adsorption (VPSA) plants to produce their own medical-grade oxygen, reducing reliance on external suppliers and mitigating logistical challenges and costs.
Integration of Technology and Telemedicine: Modern oxygen delivery systems are being integrated with smart technologies, such as remote monitoring and data tracking. This allows healthcare providers to monitor patient compliance and vitals in real-time, improving the effectiveness of oxygen therapy.
Strict Regulatory and Safety Standards: Medical oxygen is classified as a drug in many countries, subjecting its production, storage, and delivery to stringent regulations and quality controls, which can create entry barriers and increase operational costs for manufacturers.
High Costs of Logistics and Storage: The transportation and storage of liquid medical oxygen (LMO) are complex and expensive, requiring specialized cryogenic tankers and storage vessels. This is a significant logistical and financial challenge, especially in remote or underdeveloped areas.
Risks Associated with Oxygen Therapy: Improper handling and administration of medical oxygen can lead to serious safety hazards, including fire risk. Furthermore, incorrect dosage can result in medical complications like oxygen toxicity, necessitating trained personnel and careful management.
Manufacturers should prioritize innovation in portable oxygen concentrators to enhance battery life, reduce weight, and improve efficiency, catering to the growing homecare market. It is crucial to expand distribution networks and establish local partnerships in the high-growth Asia-Pacific region to capitalize on its expanding healthcare infrastructure. Furthermore, developing scalable and cost-effective on-site oxygen generation solutions will be key to addressing the needs of healthcare facilities in both developed and emerging markets, providing a significant competitive advantage.
The following regional analysis provides a detailed look at the medical oxygen market's performance and potential across the globe. Each section highlights market size projections, growth rates, and country-specific contributions to the global market, based on the projected 2025 market size. This granular view reveals distinct regional drivers, trends, and challenges that shape the global landscape.
Market Size: $883.484 Million (2021) -> $1153.22 Million (2025) -> $1965.68 Million (2033)
CAGR (2021-2033): 6.893%
Country-Specific Insight: North America is a dominant force, expected to account for approximately 35.05% of the global market in 2025. The United States is the largest contributor, representing about 27.02% of the global market. Canada and Mexico hold significant shares of 5.22% and 2.80% of the global market, respectively.
Regional Dynamics:
Drivers:
Trends:
Restraints:
Technology Focus: The region is heavily focused on next-generation Portable Oxygen Concentrators (POCs) with enhanced battery life, smart features like remote monitoring, and pulse-dose technology for efficiency. There is also a push towards integrating these devices into a connected care ecosystem.
Market Size: $664.479 Million (2021) -> $884.795 Million (2025) -> $1577.64 Million (2033)
CAGR (2021-2033): 7.497%
Country-Specific Insight: Europe is a major market, projected to hold nearly 26.89% of the global share in 2025. Germany leads the region, accounting for 5.43% of the global market, followed by the United Kingdom (4.65%), France (3.74%), and Italy (3.02%). Other countries like Russia and Spain contribute over 2% each to the global market.
Regional Dynamics:
Drivers:
Trends:
Restraints:
Technology Focus: The focus is on high-purity oxygen generation via advanced PSA and VPSA systems. In the homecare sector, there's a strong trend towards quiet, energy-efficient stationary concentrators and compact portable devices that comply with CE marking standards.
Market Size: $525.113 Million (2021) -> $743.707 Million (2025) -> $1445.07 Million (2033)
CAGR (2021-2033): 8.658%
Country-Specific Insight: As the fastest-growing region, APAC is expected to command a 22.60% share of the global market in 2025. China is a major driver, holding 8.16% of the global market, with Japan and India following closely at 4.45% and 4.18%, respectively. South Korea and Australia also make notable contributions.
Regional Dynamics:
Drivers:
Trends:
Restraints:
Technology Focus: The technology landscape is mixed. While major urban hospitals are adopting advanced on-site generation and high-end concentrators, there is still a vast demand for basic, robust, and low-cost oxygen cylinders and simple concentrators for smaller clinics and resource-limited settings.
Market Size: $161.765 Million (2021) -> $194.654 Million (2025) -> $284.229 Million (2033)
CAGR (2021-2033): 4.846%
Country-Specific Insight: South America represents a developing market, projected to hold about 5.92% of the global share in 2025. Brazil is the largest market in the region, accounting for 2.18% of the global total, followed by Argentina at 1.15%. Other countries collectively contribute to the remaining regional share.
Regional Dynamics:
Drivers:
Trends:
Restraints:
Technology Focus: The focus is on establishing reliable and resilient oxygen supply chains. This includes a combination of traditional liquid oxygen supply and the strategic installation of durable, easy-to-maintain PSA plants suited for varying environmental conditions and technical expertise levels.
Market Size: $121.946 Million (2021) -> $150.564 Million (2025) -> $226.199 Million (2033)
CAGR (2021-2033): 5.219%
Country-Specific Insight: Africa holds a growing but challenging market, accounting for an estimated 4.58% of the global market in 2025. South Africa is the most developed market on the continent, contributing 2.04% to the global share, while Nigeria accounts for approximately 0.97%.
Regional Dynamics:
Drivers:
Trends:
Restraints:
Technology Focus: Technology adoption is centered on robustness, reliability, and low maintenance. The primary focus is on implementing containerized PSA plants, durable oxygen concentrators, and cylinder-filling stations that can operate effectively in harsh and resource-limited environments.
Market Size: $131.9 Million (2021) -> $163.363 Million (2025) -> $252.482 Million (2033)
CAGR (2021-2033): 5.593%
Country-Specific Insight: The Middle East market is projected to constitute about 4.96% of the global market in 2025. High-income GCC countries lead the way, with Saudi Arabia accounting for 1.91% of the global share. Turkey and the UAE are also key markets, contributing 0.82% and 0.61% respectively.
Regional Dynamics:
Drivers:
Trends:
Restraints:
Technology Focus: The region, particularly the GCC countries, is an early adopter of premium, high-tech solutions. The focus is on fully automated, large-scale PSA and cryogenic plants for hospitals, as well as advanced portable concentrators and smart homecare monitoring systems for private patients.
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Medical Oxygen Market Sales Revenue | $ 2488.69 Million | $ 3290.3 Million | $ 5751.3 Million | 7.23% |
| North America Medical Oxygen Market Sales Revenue | $ 883.484 Million | $ 1153.22 Million | $ 1965.68 Million | 6.893% |
| United States Medical Oxygen Market Sales Revenue | $ 684.7 Million | $ 889.119 Million | $ 1505.67 Million | 6.806% |
| Canada Medical Oxygen Market Sales Revenue | $ 128.989 Million | $ 171.841 Million | $ 300.788 Million | 7.249% |
| Mexico Medical Oxygen Market Sales Revenue | $ 69.795 Million | $ 92.257 Million | $ 159.22 Million | 7.059% |
| Europe Medical Oxygen Market Sales Revenue | $ 664.479 Million | $ 884.795 Million | $ 1577.64 Million | 7.497% |
| United Kingdom Medical Oxygen Market Sales Revenue | $ 116.284 Million | $ 153.052 Million | $ 266.558 Million | 7.181% |
| Germany Medical Oxygen Market Sales Revenue | $ 132.231 Million | $ 178.746 Million | $ 326.634 Million | 7.827% |
| France Medical Oxygen Market Sales Revenue | $ 94.356 Million | $ 122.969 Million | $ 216.073 Million | 7.3% |
| Italy Medical Oxygen Market Sales Revenue | $ 73.757 Million | $ 99.292 Million | $ 180.545 Million | 7.76% |
| Russia Medical Oxygen Market Sales Revenue | $ 55.152 Million | $ 73.898 Million | $ 132.585 Million | 7.58% |
| Spain Medical Oxygen Market Sales Revenue | $ 51.165 Million | $ 72.571 Million | $ 130.849 Million | 7.647% |
| Sweden Medical Oxygen Market Sales Revenue | $ 15.948 Million | $ 21.04 Million | $ 37.011 Million | 7.315% |
| Denmark Medical Oxygen Market Sales Revenue | $ 11.296 Million | $ 14.758 Million | $ 25.81 Million | 7.237% |
| Switzerland Medical Oxygen Market Sales Revenue | $ 15.283 Million | $ 19.979 Million | $ 35.118 Million | 7.305% |
| Luxembourg Medical Oxygen Market Sales Revenue | $ 14.619 Million | $ 19.749 Million | $ 35.402 Million | 7.569% |
| Rest of Europe Medical Oxygen Market Sales Revenue | $ 84.389 Million | $ 108.741 Million | $ 191.052 Million | 7.299% |
| Asia Pacific Medical Oxygen Market Sales Revenue | $ 525.113 Million | $ 743.707 Million | $ 1445.07 Million | 8.658% |
| China Medical Oxygen Market Sales Revenue | $ 185.89 Million | $ 268.5 Million | $ 533.318 Million | 8.957% |
| Japan Medical Oxygen Market Sales Revenue | $ 103.972 Million | $ 146.488 Million | $ 281.702 Million | 8.517% |
| India Medical Oxygen Market Sales Revenue | $ 92.42 Million | $ 137.608 Million | $ 278.985 Million | 9.236% |
| South Korea Medical Oxygen Market Sales Revenue | $ 45.685 Million | $ 58.731 Million | $ 106.849 Million | 7.768% |
| Australia Medical Oxygen Market Sales Revenue | $ 25.205 Million | $ 36.166 Million | $ 71.329 Million | 8.86% |
| Singapore Medical Oxygen Market Sales Revenue | $ 14.703 Million | $ 20.504 Million | $ 39.364 Million | 8.494% |
| South East Asia Medical Oxygen Market Sales Revenue | $ 35.708 Million | $ 49.955 Million | $ 95.288 Million | 8.407% |
| Taiwan Medical Oxygen Market Sales Revenue | $ 9.977 Million | $ 13.513 Million | $ 24.48 Million | 7.71% |
| South America Medical Oxygen Market Sales Revenue | $ 161.765 Million | $ 194.654 Million | $ 284.229 Million | 4.846% |
| Brazil Medical Oxygen Market Sales Revenue | $ 59.044 Million | $ 71.835 Million | $ 105.756 Million | 4.953% |
| Argentina Medical Oxygen Market Sales Revenue | $ 31.221 Million | $ 37.965 Million | $ 55.732 Million | 4.915% |
| Colombia Medical Oxygen Market Sales Revenue | $ 14.397 Million | $ 17.226 Million | $ 24.858 Million | 4.691% |
| Peru Medical Oxygen Market Sales Revenue | $ 11.162 Million | $ 13.17 Million | $ 18.879 Million | 4.604% |
| Chile Medical Oxygen Market Sales Revenue | $ 11 Million | $ 12.956 Million | $ 18.822 Million | 4.779% |
| Rest of South America Medical Oxygen Market Sales Revenue | $ 34.941 Million | $ 41.501 Million | $ 60.184 Million | 4.756% |
| Middle East Medical Oxygen Market Sales Revenue | $ 131.9 Million | $ 163.363 Million | $ 252.482 Million | 5.593% |
| Saudi Arabia Medical Oxygen Market Sales Revenue | $ 51.045 Million | $ 62.887 Million | $ 96.398 Million | 5.484% |
| Turkey Medical Oxygen Market Sales Revenue | $ 21.5 Million | $ 26.963 Million | $ 42.947 Million | 5.991% |
| UAE Medical Oxygen Market Sales Revenue | $ 15.96 Million | $ 20.102 Million | $ 31.838 Million | 5.917% |
| Egypt Medical Oxygen Market Sales Revenue | $ 12.399 Million | $ 15.283 Million | $ 23.531 Million | 5.543% |
| Qatar Medical Oxygen Market Sales Revenue | $ 10.42 Million | $ 12.8 Million | $ 19.694 Million | 5.534% |
| Rest of Middle East Medical Oxygen Market Sales Revenue | $ 20.576 Million | $ 25.329 Million | $ 38.074 Million | 5.227% |
| Africa Medical Oxygen Market Sales Revenue | $ 121.946 Million | $ 150.564 Million | $ 226.199 Million | 5.219% |
| Nigeria Medical Oxygen Market Sales Revenue | $ 25.852 Million | $ 31.82 Million | $ 47.633 Million | 5.172% |
| South Africa Medical Oxygen Market Sales Revenue | $ 54.144 Million | $ 67.161 Million | $ 101.59 Million | 5.309% |
Medical Oxygen Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The medical oxygen market is an essential sector within the healthcare industry, dedicated to providing vital oxygen therapy to patients with respiratory conditions and other medical needs. Oxygen therapy is a cornerstone of medical treatment, supporting patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and respiratory failure. The market encompasses a wide range of products and services, including oxygen cylinders, concentrators, liquid oxygen systems, delivery devices, and related accessories. Key players in the medical oxygen market include manufacturers, distributors, healthcare providers, and regulatory authorities, all working together to ensure the availability, safety, and quality of medical oxygen products and services. With the increasing prevalence of respiratory diseases, aging populations, and the heightened demand for oxygen therapy during public health emergencies such as the COVID-19 pandemic, the medical oxygen market plays a critical role in delivering life-saving respiratory care to patients worldwide.
In March 2024, Building the silent I.C.U. of the future: Philips will demonstrate a collaborative approach to interoperability at #HIMSS24. Health Tech manufacturers collaborate with SDC-enabled technology to create a more peaceful healing environment for patients and a streamlined workflow for clinicians.
The increasing prevalence of respiratory diseases globally is expected to drive a surge in demand for medical oxygen. Respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and respiratory failure are becoming more prevalent due to factors such as air pollution, smoking, aging populations, and respiratory infections. As these conditions lead to impaired lung function and difficulty breathing, medical oxygen therapy plays a crucial role in providing relief and supporting patients' respiratory needs. Additionally, the COVID-19 pandemic has further highlighted the importance of oxygen therapy in managing severe respiratory symptoms and preventing respiratory failure in critically ill patients. With the rising burden of respiratory diseases worldwide, the demand for medical oxygen is expected to increase significantly, necessitating investments in oxygen production, distribution, and healthcare infrastructure to meet the growing healthcare needs of populations globally.
The aging population is poised to be a significant driver of market growth in the medical oxygen sector. As demographics shift towards an older population demographic globally, the prevalence of age-related health conditions, including respiratory illnesses, tends to rise. Elderly individuals are more susceptible to chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections. These conditions often necessitate the use of medical oxygen therapy to alleviate symptoms and improve quality of life. Moreover, as individuals age, their lung function naturally declines, leading to an increased likelihood of requiring respiratory support. The growing aging population worldwide is, therefore, expected to fuel the demand for medical oxygen as a vital therapy for managing respiratory conditions among older adults. This demographic trend underscores the importance of investing in medical oxygen production, distribution, and healthcare infrastructure to adequately meet the needs of an aging population and ensure access to essential respiratory care services.
Limited access to healthcare presents a significant constraint on the sales of medical oxygen products and services. In many regions, particularly in low-income countries and underserved rural areas, access to healthcare facilities and medical services, including oxygen therapy, is limited. Factors contributing to this limitation include inadequate healthcare infrastructure, a shortage of trained healthcare professionals, and socioeconomic barriers such as poverty and lack of health insurance. As a result, many individuals with respiratory conditions and other medical needs may not receive timely access to essential oxygen therapy, leading to preventable complications and poorer health outcomes. Limited access to healthcare exacerbates disparities in healthcare delivery and contributes to inequities in health outcomes among different populations. Addressing this challenge requires concerted efforts from governments, healthcare organizations, and non-governmental organizations to improve healthcare infrastructure, expand access to medical services, and implement initiatives to ensure universal access to essential healthcare services, including medical oxygen therapy, for all individuals regardless of their socioeconomic status or geographical location.
The COVID-19 pandemic has had a profound impact on the medical oxygen market, driving unprecedented demand for oxygen therapy worldwide. As the virus primarily affects the respiratory system, many COVID-19 patients experience severe respiratory symptoms, including acute respiratory distress syndrome (ARDS), necessitating urgent oxygen therapy and, in some cases, mechanical ventilation. The surge in COVID-19 cases overwhelmed healthcare systems, leading to shortages of medical oxygen in many regions. Hospitals and healthcare facilities faced challenges in sourcing adequate oxygen supplies, resulting in critical shortages and tragic consequences for patients in need. The unprecedented demand for medical oxygen during the pandemic highlighted the importance of robust oxygen supply chains, resilient healthcare infrastructure, and strategic planning for public health emergencies. Additionally, the COVID-19 pandemic accelerated investments in oxygen production capacity, distribution networks, and healthcare infrastructure to ensure readiness for future crises.
We have various report editions of Medical Oxygen Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.
In February 2024, Intel announced the official launch of Altera, its new standalone FPGA company. During the FPGA Vision Webcast, Chief Executive Officer Sandra Rivera and Chief Operating Officer Shannon Poulin unveiled their strategy to secure leadership across a $55 billion-plus market opportunity, expand the company's portfolio, including the only FPGA with A.I. built into the fabric, and help solve mounting customer challenges. They also announced Altera as the new company's brand.
(Source: https://precisionmedical.com/supplements-and-home-remedies-to-help-relieve-sinus-infections/)
In January 2024, With the GA F.L.X., Atlas Copco introduced an entirely new rotary screw compressor type: the dual-speed compressor. It operates at two speeds, one for maximum capacity and a minimum speed, to reduce energy consumption during unloading. As a result, it is up to 20% more efficient than a traditional fixed-speed compressor.
(Source: https://www.atlascopco.com/en-in/compressors/air-compressor-blog/dual-speed-technolog/)
Top Companies Market Share in Medical Oxygen Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Koninklijke Philips N.V | xxxx | xxxx | xxxx | xxxx |
| Inogen | xxxx | xxxx | xxxx | xxxx |
| B.O.C. Healthcare | xxxx | xxxx | xxxx | xxxx |
| Precision Medical | xxxx | xxxx | xxxx | xxxx |
| Luxfer Group | xxxx | xxxx | xxxx | xxxx |
| Cryofab | xxxx | xxxx | xxxx | xxxx |
| Responsive Respiratory | xxxx | xxxx | xxxx | xxxx |
| Atlas Copco | xxxx | xxxx | xxxx | xxxx |
| G.C.E. group | xxxx | xxxx | xxxx | xxxx |
| High Vacuum Maintenance (H.V.M.) S.R.L. | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. The region's leading position can be attributed to several factors, including the well-established healthcare infrastructure, high prevalence of respiratory diseases, significant healthcare expenditure, and advanced technology adoption. Moreover, stringent regulatory standards and robust healthcare systems in countries like the United States and Canada contribute to ensuring the quality and safety of medical oxygen products and services.
The Asia Pacific region is witnessing an increase in COPD, contributing to increased demand for medical oxygen. Factors such as rapid urbanization, aging populations, air pollution, and smoking prevalence are driving the prevalence of COPD across the region. COPD is a progressive respiratory condition characterized by airflow limitation and breathing difficulties, necessitating oxygen therapy for symptom management and improved quality of life.
The current report Scope analyzes Medical Oxygen Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Medical Oxygen Market size was estimated at USD 3154.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1261.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. In North America, Liquid oxygen emerged as the dominant segment in the medical oxygen market over the forecast period, holding the major market share. Liquid oxygen is favored for its high oxygen concentration and efficient storage and delivery capabilities. It is suitable for patients requiring high-flow oxygen therapy and healthcare facilities with high-demand requirements. The segment's dominance can be attributed to its advantages in terms of reliability, continuous supply, and convenience, particularly in critical care settings.
According to Cognitive Market Research, with a market value of USD 3154.2 million in 2024, it is projected to expand at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 946.26 million. In Europe, Liquid oxygen emerged as the dominant segment in the medical oxygen market over the forecast period, holding the major market share. Liquid oxygen is favored for its high oxygen concentration and efficient storage and delivery capabilities. It is suitable for patients requiring high-flow oxygen therapy and healthcare facilities with high-demand requirements. The segment's dominance can be attributed to its advantages in terms of reliability, continuous supply, and convenience, particularly in critical care settings.
According to Cognitive Market Research, the global Medical Oxygen Market size was estimated at USD 3154.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 725.47 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031. The Asia Pacific region is experiencing growth in COPD. COPD is a prevalent respiratory condition characterized by airflow limitation and breathing difficulties, necessitating long-term oxygen therapy for many patients. As COPD continues to be a leading cause of morbidity and mortality worldwide, the demand for medical oxygen therapy remains high. Healthcare providers prioritize COPD management through oxygen therapy to alleviate symptoms, improve quality of life, and reduce the risk of exacerbations. Given the significant burden of COPD on healthcare systems globally, the condition's prominent market share underscores the importance of oxygen therapy in addressing the respiratory care needs of COPD patients. It highlights the COPD segment's pivotal role in driving growth in the medical oxygen market.
According to Cognitive Market Research, the global Medical Oxygen Market size was estimated at USD 3154.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 157.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031. COPD in Latin America is experiencing growth. COPD is a prevalent respiratory condition characterized by airflow limitation and breathing difficulties, necessitating long-term oxygen therapy for many patients. As COPD continues to be a leading cause of morbidity and mortality worldwide, the demand for medical oxygen therapy remains high. Healthcare providers prioritize COPD management through oxygen therapy to alleviate symptoms, improve quality of life, and reduce the risk of exacerbations. Given the significant burden of COPD on healthcare systems globally, the condition's prominent market share underscores the importance of oxygen therapy in addressing the respiratory care needs of COPD patients. It highlights the COPD segment's pivotal role in driving growth in the medical oxygen market.
According to Cognitive Market Research, the global Medical Oxygen Market size was estimated at USD 3154.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 63.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031. Hospitals maintain a prominent market share in the medical oxygen segment. As primary providers of acute and critical care services, hospitals require a consistent and reliable supply of medical oxygen to support patients with respiratory conditions, emergencies, surgical procedures, and intensive care needs. The demand for medical oxygen in hospitals is driven by the high volume of patients requiring oxygen therapy across various departments, including emergency rooms, intensive care units, operating rooms, and general wards.
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Medical Oxygen Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Medical Oxygen Industry growth. Medical Oxygen market has been segmented with the help of its Form, Application End-User, and others. Medical Oxygen market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, Liquid Oxygen held the major market share over the forecast period. Liquid oxygen is favored for its high oxygen concentration and efficient storage and delivery capabilities. It is suitable for patients requiring high-flow oxygen therapy and healthcare facilities with high-demand requirements. The segment's dominance can be attributed to its advantages in terms of reliability, continuous supply, and convenience, particularly in critical care settings.
Compressed oxygen cylinders are the fastest-growing category over the forecast period. This growth can be attributed to several factors, including their versatility, cost-effectiveness, and ease of storage and transportation. Compressed oxygen cylinders offer a convenient and portable solution for delivering oxygen therapy to patients in various healthcare settings, including hospitals, clinics, and home care environments.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Medical Oxygen Industry. Request a Free Sample PDF!
According to Cognitive Market Research, COPD holds a prominent market share. COPD is a prevalent respiratory condition characterized by airflow limitation and breathing difficulties, necessitating long-term oxygen therapy for many patients. As COPD continues to be a leading cause of morbidity and mortality worldwide, the demand for medical oxygen therapy remains high. Healthcare providers prioritize COPD management through oxygen therapy to alleviate symptoms, improve quality of life, and reduce the risk of exacerbations.
Lung Disorders are the fastest-growing category over the forecast period. With an increasing prevalence of respiratory conditions globally, including asthma, pneumonia, and interstitial lung diseases, the demand for oxygen therapy to manage these disorders is on the rise. Lung disorders encompass a wide range of conditions that affect lung function and oxygenation, necessitating oxygen therapy to support patients' respiratory needs.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, Hospitals hold a prominent market share. As primary providers of acute and critical care services, hospitals require a consistent and reliable supply of medical oxygen to support patients with respiratory conditions, emergencies, surgical procedures, and intensive care needs. The demand for medical oxygen in hospitals is driven by the high volume of patients requiring oxygen therapy across various departments, including emergency rooms, intensive care units, operating rooms, and general wards.
Emergency Medical Centers are the fastest-growing category over the forecast period. With an increasing emphasis on emergency preparedness and response, coupled with rising demand for immediate medical attention in critical situations, the need for medical oxygen in emergency medical centers is on the rise. These centers serve as vital hubs for providing urgent medical care to patients experiencing acute respiratory distress, cardiac emergencies, trauma injuries, and other life-threatening conditions.
According to Cognitive Market Research, 96% to 99.5% holds a prominent market share, driven by its critical role in various healthcare applications. This concentration range is particularly valued for its high purity, making it suitable for specialized medical procedures, respiratory therapy, and critical care settings where precise oxygen delivery is essential. Healthcare providers rely on oxygen concentrations within this range for conditions requiring elevated oxygen levels, such as hyperbaric oxygen therapy, neonatal care, and certain respiratory conditions.
The 93% to 96% oxygen concentration range emerges as the fastest-growing category in the medical oxygen market over the forecast period. This concentration range is particularly crucial for patients requiring precise oxygen therapy dosing, such as those with respiratory conditions like COPD or acute respiratory distress syndrome (ARDS). The demand for oxygen concentrations within this range is driven by the need for tailored oxygen therapy to optimize patient outcomes while minimizing the risk of hyperoxia or hypoxia.
According to Cognitive Market Research, Aerial Diffusion holds a prominent market share, driven by its effectiveness in delivering oxygen therapy to patients in various healthcare settings. Aerial diffusion systems, such as oxygen masks and nasal cannulas, are widely utilized for their ability to deliver oxygen to patients through inhalation efficiently. These devices offer flexibility, ease of use, and patient comfort, making them the preferred choice for oxygen therapy in hospitals, clinics, emergency rooms, and home care settings. Moreover, advancements in aerial diffusion technology have led to the development of innovative oxygen delivery devices, further enhancing their effectiveness and performance.
Direct Inhalation is the fastest-growing category over the forecast period. This growth is driven by the increasing recognition of the efficiency and effectiveness of direct inhalation methods for delivering oxygen therapy to patients. Direct inhalation devices, such as oxygen masks and nasal cannulas, offer a direct route for oxygen delivery to the lungs, ensuring rapid absorption and optimal oxygenation levels in patients with respiratory conditions. Moreover, advancements in direct inhalation technology, including improved designs and materials, enhance patient comfort, compliance, and therapeutic outcomes.
According to Cognitive Market Research, Portable Medical Oxygen Systems hold a prominent market share, driven by their versatility, convenience, and increasing demand for mobile healthcare solutions. These systems allow patients to receive oxygen therapy outside traditional healthcare settings, such as in their homes, during travel, or while engaging in daily activities. Portable oxygen concentrators, cylinders, and liquid oxygen systems offer reliable oxygen delivery, allowing patients with respiratory conditions to maintain their mobility and independence.
Standalone Medical Oxygen Systems is the fastest-growing category over the forecast period. This growth is driven by the increasing demand for standalone oxygen solutions that do not rely on centralized oxygen supply systems or infrastructure. Standalone systems provide healthcare facilities, clinics, and home care settings with flexibility, autonomy, and redundancy in oxygen supply, ensuring continuous access to oxygen therapy even in the event of power outages or system failures.
Disclaimer:
| Form | Liquid Oxygen , Compressed , Oxygen Concentrators , Others |
| Application | COPD , Bronchopulmonary , Lung Disorder , Heart Failure , Asthma , Cystic Fibrosis , Others |
| End-User | Hospitals , Ambulatory Centres , Emergency Medical Centres , Homecare |
| Purity | 96% to 99.5% , 93% to 96% |
| Delivery | Aerial Diffusion , Direct Inhalation , Others |
| Modality | Portable Medical Oxygen Systems , Standalone Medical Oxygen Systems , Market Split by Technology , Continuous Flow , Pulse Dose |
| List of Competitors | Koninklijke Philips N.V, Inogen, B.O.C. Healthcare, Precision Medical, Luxfer Group, Cryofab, Responsive Respiratory, Atlas Copco, G.C.E. group, High Vacuum Maintenance (H.V.M.) S.R.L. |
Chapter 1 2026 Geopolitical Outlook - Medical Oxygen Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review Global Medical Oxygen Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review North America Medical Oxygen Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review Europe Medical Oxygen Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review Asia Pacific Medical Oxygen Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review South America Medical Oxygen Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review Middle East Medical Oxygen Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Medical Oxygen. Further deep in this chapter, you will be able to review Middle East Medical Oxygen Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Medical Oxygen. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Form Analysis 2019 -2031, will provide market size split by Form. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Form Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End-User Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 15 Market Split by Purity Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 16 Market Split by Delivery Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 17 Market Split by Modality Analysis 2022 - 2034
Chapter 18 Medical Oxygen Price Trend Analysis
Chapter 19 Gap Analysis
Chapter 20 Strategy Analysis
Chapter 21 Profitability and Gross Margin Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Medical Oxygen market
Chapter 22 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 23 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.